A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Clinical trial NCT04153981 · COMPLETED
Trial details
- NCT number
- NCT04153981
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2021-07-30
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.